Apple has announced that it will open up its Health Records application programming interface (API) to developers and researchers this autumn so that they can create an ecosystem of apps that use health record data to better manage medications, nutrition plans and diagnosed diseases.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh